Literature DB >> 24700702

Association of differential β-catenin expression with Oct-4 and Nanog in oral squamous cell carcinoma and their correlation with clinicopathological factors and prognosis.

Gokulan Ravindran1, Sharada S Sawant2, Angela Hague3, Karl Kingsley4, Halagowder Devaraj1.   

Abstract

BACKGROUND: The re-expression of pluripotent markers (Oct-4 and Nanog) and the reactivation of stem cell-related pathways in oral carcinoma have been well researched. However, the relationship between the stem cell signaling molecule β-catenin and pluripotent markers Oct-4 and Nanog in oral cancer is yet to be studied in detail. Therefore, we have investigated the correlation among Oct-4, Nanog, and β-catenin in oral squamous cell carcinoma, which, in turn, could provide valuable insight into its prognostic significance.
METHODS: The immunohistochemical analysis was performed for 60 cases of oral cancer to study the expression pattern of Oct-4, Nanog, and β-catenin. Whereas immunofluorescence analysis was used to investigate the co-localization of β-catenin with Oct-4 and Nanog in oral carcinoma tissues and H314 cell line. Finally, co-immunoprecipitation analysis was used to study the possible interaction between β-catenin and Oct-4 in oral carcinoma cells.
RESULTS: β-catenin, Oct-4, and Nanog showed significant correlation with lymph node metastasis, stage, grade, and prognosis in oral squamous cell carcinoma. Interestingly, a significant positive correlation was found among the expression of Oct-4, Nanog, and β-catenin. Moreover, the interaction between β-catenin and Oct-4 was observed in oral cancer.
CONCLUSION: The positive correlation among Oct-4, Nanog, and β-catenin suggests their coordinated role in maintaining proliferation in oral carcinoma cells. The interaction between β-catenin and Oct-4 may be a crucial event in oral carcinogenesis. On the other hand, β-catenin, Oct-4, and Nanog could be used as independent prognostic markers of oral squamous cell carcinoma.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Nanog; Oct-4; cancer stem cells; oral squamous cell carcinoma; β-catenin

Mesh:

Substances:

Year:  2014        PMID: 24700702     DOI: 10.1002/hed.23699

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  19 in total

Review 1.  NANOG expression in human development and cancerogenesis.

Authors:  Gašper Grubelnik; Emanuela Boštjančič; Ana Pavlič; Marina Kos; Nina Zidar
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-10

Review 2.  Role of OCT4 in cancer stem-like cells and chemotherapy resistance.

Authors:  Ismail S Mohiuddin; Sung-Jen Wei; Min H Kang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-03-21       Impact factor: 5.187

3.  Prognostic implication of NOTCH1 in early stage oral squamous cell cancer with occult metastases.

Authors:  Shan Wang; Haixia Fan; Jiankai Xu; Eryang Zhao
Journal:  Clin Oral Investig       Date:  2017-09-02       Impact factor: 3.573

4.  Prognostic role of Oct4, CD44 and c-Myc in radio-chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient mice.

Authors:  Sharada Sawant; Ravindran Gokulan; Harsh Dongre; Milind Vaidya; Devendra Chaukar; Kumar Prabhash; Arvind Ingle; Shriya Joshi; Prerana Dange; Shreyas Joshi; Archana Kumari Singh; Vidhi Makani; Shilpi Sharma; Ashok Jeyaram; Shubhada Kane; Anil D'Cruz
Journal:  Clin Oral Investig       Date:  2015-04-28       Impact factor: 3.573

Review 5.  Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena.

Authors:  Richard T Bryan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-02-05       Impact factor: 6.237

6.  Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.

Authors:  Carola H Schrader; Markus Kolb; Karim Zaoui; Christa Flechtenmacher; Niels Grabe; Klaus-Josef Weber; Thomas Hielscher; Peter K Plinkert; Jochen Hess
Journal:  Mol Cancer       Date:  2015-05-20       Impact factor: 27.401

7.  Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma.

Authors:  Hye-Jin Lee; Young-Hoon Kang; Jong-Sil Lee; June-Ho Byun; Uk-Kyu Kim; Si-Jung Jang; Gyu-Jin Rho; Bong-Wook Park
Journal:  BMC Oral Health       Date:  2015-12-01       Impact factor: 2.757

8.  Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis.

Authors:  Zhaona Fan; Mianxiang Li; Xiaobing Chen; Juan Wang; Xueyi Liang; Hongfei Wang; Zhi Wang; Bin Cheng; Juan Xia
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

Review 9.  Prognostic significance of NANOG expression in solid tumors: a meta-analysis.

Authors:  Lingqiong Zhao; Jie Liu; Shu Chen; Chun Fang; Xianquan Zhang; Zhibin Luo
Journal:  Onco Targets Ther       Date:  2018-09-06       Impact factor: 4.147

10.  Midkine and NANOG Have Similar Immunohistochemical Expression Patterns and Contribute Equally to an Adverse Prognosis of Oral Squamous Cell Carcinoma.

Authors:  Hyun-Min Kim; Young-Hoon Kang; June-Ho Byun; Si-Jung Jang; Gyu-Jin Rho; Jong-Sil Lee; Bong-Wook Park
Journal:  Int J Mol Sci       Date:  2017-11-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.